Cannabis Law Report

AUGUST 26, 2022

CBD has been suggested to act as a treatment for sclerosis symptoms, as well as epilepsy among children. Apart from this, various clinical trials are done for multiple conditions. Seizures and epilepsy are serious medical conditions. Epilepsy is known to alter the rhythmic electrical impulse pattern. Dehydration.

Epilepsy 52

Epilepsy Treatment CBD Sleep 52

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

AUGUST 17, 2021

We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. percent, consistent with the Marigold Phase 3 CDKL5 deficiency disorder trial of 24.5 Chief Medical Officer of Marinus. “We Data Highlights.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Cannabis Law Report

SEPTEMBER 9, 2021

Supera-CBD is being developed to address anxiety, chronic pain, addiction, and seizures, and is on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 74

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 74

MMJ Recs

DECEMBER 17, 2023

Let’s take a deeper dive into the various MMJ laws in Texas, exploring the regulations, qualifying conditions, dosage guidelines, purchasing options, and access process for medical marijuana in the Lone Star State. Current Texas Medical Marijuana Regulations CBD laws in Texas are governed by the Compassionate Use Program.

Law 52

Law Clinical Trials Dispensary Programs 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Cannabis Law Report

AUGUST 21, 2019

PUBLISHER: CANNABIS LAW REPORT. The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Therapy 40

Cannabis Law Report

AUGUST 2, 2021

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. Securities and Exchange Commission.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., For more information, please visit www.virpaxpharma.com. About Altasciences.

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Data 40

Veriheal

JULY 7, 2023

The new law covers the use of MDMA and psilocybin to treat certain conditions. Canada, and Israel are all conducting clinical trials on psychedelic treatments. Rabon’s bill seeks to give patients with qualifying conditions like cancer, epilepsy, PTSD, and multiple sclerosis access to medical cannabis. Currently, the U.S.,

Legalization 97

Legalization Clinical Trials Research and Development History 97

Cannabis Law Report

AUGUST 19, 2021

Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed. Under UK drugs law, it is not possible for British companies to produce CBD because they are compelled to destroy the CBD-rich flower or bud of the hemp plant.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Veriheal

APRIL 11, 2022

federal law , it has not yet been used in any commonly prescribed medicines. The company initiated the first legal transfer (as deemed by federal law) to the U.S. Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials. federal law.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

United Patients Group

JANUARY 8, 2023

Cannabis has also been used for centuries to treat gastrointestinal disorders, epilepsy, rheumatism and malaria. Many neurological conditions are associated with dysregulation of the ECS (for example: epilepsy, Parkinson’s disease). Ancient Chinese texts and Ayurvedic texts describe its use to treat inflammation, pain and spasms.

Blood Pressure 122

Blood Pressure Sleep Cannabinoids Clinical Trials 122

Cannabis Law Report

MARCH 21, 2019

New laws and bills are constantly being passed that create a great deal of confusion in the cannabis world. Is CBD Legal Under Federal Law? Only CBD products produced in compliance with the Farm Bill would be legal by federal law. Most states have different laws and regulations individually pertaining to CBD and marijuana.

State Laws 55

State Laws Law CBD Legalization 55

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The therapeutic role of Cannabidiol in mental health may grow in the future as more states and local governments alter their existing cannabis laws and allow for the greater access and testing of cannabis for medical purposes.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Veriheal

MARCH 23, 2023

One of the proposed bills would amend the Cannabis Control Law during the current 150-day Diet session, which launched on Monday, January 23. Based on Japan’s Cannabis Control Law—A.K.A. ‘1948 Law No. Moving forward, the government plans on implementing new laws as a way of preventing drug abuse among young people.

Legalization 81

Legalization Marijuana Clinical Trials Seed-To-Sale 81

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. The recent years have seen drastic marijuana law changes in several states. Cannabis Legalization Throughout The Country.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Medicinal Marijuana Association

AUGUST 27, 2019

Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Cannabis Law Report

SEPTEMBER 20, 2021

Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children.

Epilepsy 40

Epilepsy Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

DECEMBER 23, 2021

The story of GW Pharmaceuticals, the producers of Epidiolex, is instructive regarding the challenges and opportunities of operating in the pharmaceutical cannabis space; taking over 20 years to generate considerable sales and facing several setbacks in clinical trials. The current medical cannabis market is bursting with innovation.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

Cannabis Law Report

MARCH 7, 2022

High-profile cases of parents campaigning for access to cannabis oil for severe and rare forms of epilepsy in their children are the most recent in a long line of controversies over cannabis and cannabis-based medicines. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines.

Clinical Trials 52

Clinical Trials Policy History Epilepsy 52

SpeedWeed

MARCH 30, 2021

Anthony Ordman is Honorary Medical Director of Integro Medical Clinics – one of the 20-plus private clinics to have emerged since the law change in 2018. Private Clinic Happy To Help. “By Arjun Rajyagor, COO, said: “The NHS are taking steps in the right direction by collecting clinical outcomes.

Data 52

Data Patients Clinical Trials Business 52

CannaMD

AUGUST 8, 2020

And, importantly, it puts no restrictions on the sale, transport, or possession of hemp-derived products, so long as those items are produced in a manner consistent with the law. All other cannabinoids (such as THC and THCV), produced in any other setting, remain a Schedule I substance under federal law and are thus illegal.

CBD 105

CBD DEA Research and Development Hemp 105

Cannabis Law Report

SEPTEMBER 6, 2021

Clinical trials, research and development (R&D) activities and commercialization of cannabis-based indications are further expected to catalyze the growth of the market. 12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications. Key Topics Covered: 1 Preface. 4 Introduction.

Chronic Pain 66

Chronic Pain Research and Development Clinical Trials Epilepsy 66

Cannabis Law Report

JANUARY 26, 2022

The Innovation Passport does not reduce the burden of demonstrating that a treatment may be safe and effective, but does provide research organizers with expert advice, patient input, and collaboration throughout the clinical trial design and development process through a product-specific Target Development Profile.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

NOVEMBER 1, 2021

Imports seized by customs found to contain traces of drugs banned under Hong Kong’s strict laws. The difficulty for traders and users of products containing cannabidiol – CBD for short, which is legal – lies in ensuring they do not also have other substances that run afoul of Hong Kong’s strict drug laws.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Global Legal Cannabis Industry: Number of Clinical Trials, By Region. Market Segmentation. Market Dynamics.

Recreational 73

Recreational Hemp THC Legalization 73

Cannabis Law Report

AUGUST 26, 2019

In June 2018, the Food and Drug Administration (FDA) approved the use of a treatment that consists of cannabidiol (CBD) to treat two rare and severe specific types of epilepsy, which are known as Lennox-Gastaut syndrome, and the other is Dravet syndrome. The approval is based on the research and clinical trials.

Chronic Pain 45

Chronic Pain Clinical Trials Epilepsy Conditions 45

Cannabis Law Report

NOVEMBER 29, 2019

For instance, THC has shown the potential to help in the treatment of conditions like PTSD, depression, eating disorders, and epilepsy. Clinical trials are also underway to determine the possibility of THC, cannabis, and other cannabinoids to help with obesity and appetite. That’s why some people choose THC oil. THC Oil Effects.

Oil 80

Oil THC Cannabinoids Research and Development 80

Cannabis Law Report

JUNE 7, 2022

Did you know that CBD is approved to treat seizures caused by different types of epilepsy? This was when clinical trials found a significant reduction in seizures for people who took CBD. While more data is needed to confirm all these, its effects on our physical bodies show promise so far. Alleviates Seizures.

Chronic Pain 52

Chronic Pain CBD Digestion Edibles 52

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Topical 40

Cannabis Law Report

NOVEMBER 24, 2019

Severe treatment-resistant epilepsy. Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

MARCH 2, 2020

First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). Back in 2018, the DEA rescheduled GW Pharmaceuticals ‘ (NASDAQ: GWPH) cannabis-based epilepsy medicine, Epidiolex, following its regulatory approval by the FDA.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59